Soliris Biosimilars Edge Closer In Brazil

 
• By Francesca Bruce

Court’s “mailbox” patent decision opens door to competition for Alexion’s Soliris in Brazil.

BrazilMap_1200x675
Biosimilar Soliris On The Cards In Brazil

More from Biosimilars

More from Biosimilars & Generics